Knockdown of AGR2 expression in MPanc-96 pancreatic cancer cell line and in SEG-1 esophageal adenocarcinoma cell line results in significant reduction of in vivo tumor growth [19, 20]. This evidence concerns the gene AGR2 and familial pancreatic carcinoma.